These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 14732718
1. Type IV collagen is transcriptionally regulated by Smad1 under advanced glycation end product (AGE) stimulation. Abe H, Matsubara T, Iehara N, Nagai K, Takahashi T, Arai H, Kita T, Doi T. J Biol Chem; 2004 Apr 02; 279(14):14201-6. PubMed ID: 14732718 [Abstract] [Full Text] [Related]
2. Transcription factor 7-like 2 (TCF7L2) regulates activin receptor-like kinase 1 (ALK1)/Smad1 pathway for development of diabetic nephropathy. Araoka T, Abe H, Tominaga T, Mima A, Matsubara T, Murakami T, Kishi S, Nagai K, Doi T. Mol Cells; 2010 Sep 02; 30(3):209-18. PubMed ID: 20803090 [Abstract] [Full Text] [Related]
3. Expression of Smad1 is directly associated with mesangial matrix expansion in rat diabetic nephropathy. Matsubara T, Abe H, Arai H, Nagai K, Mima A, Kanamori H, Sumi E, Takahashi T, Matsuura M, Iehara N, Fukatsu A, Kita T, Doi T. Lab Invest; 2006 Apr 02; 86(4):357-68. PubMed ID: 16482100 [Abstract] [Full Text] [Related]
4. Activation of STAT3/Smad1 is a key signaling pathway for progression to glomerulosclerosis in experimental glomerulonephritis. Takahashi T, Abe H, Arai H, Matsubara T, Nagai K, Matsuura M, Iehara N, Yokode M, Nishikawa S, Kita T, Doi T. J Biol Chem; 2005 Feb 25; 280(8):7100-6. PubMed ID: 15591053 [Abstract] [Full Text] [Related]
5. Advanced glycation end products increase collagen-specific chaperone protein in mouse diabetic nephropathy. Ohashi S, Abe H, Takahashi T, Yamamoto Y, Takeuchi M, Arai H, Nagata K, Kita T, Okamoto H, Yamamoto H, Doi T. J Biol Chem; 2004 May 07; 279(19):19816-23. PubMed ID: 15004023 [Abstract] [Full Text] [Related]
6. The role of the BMP4/Smad1 signaling pathway in mesangial cell proliferation: A possible mechanism of diabetic nephropathy. Chen C, Lin J, Li L, Zhu T, Gao L, Wu W, Liu Q, Ou S. Life Sci; 2019 Mar 01; 220():106-116. PubMed ID: 30708099 [Abstract] [Full Text] [Related]
7. Activation of bone morphogenetic protein 4 signaling leads to glomerulosclerosis that mimics diabetic nephropathy. Tominaga T, Abe H, Ueda O, Goto C, Nakahara K, Murakami T, Matsubara T, Mima A, Nagai K, Araoka T, Kishi S, Fukushima N, Jishage K, Doi T. J Biol Chem; 2011 Jun 03; 286(22):20109-16. PubMed ID: 21471216 [Abstract] [Full Text] [Related]
8. Role of Smad1 in diabetic nephropathy: Molecular mechanisms and implications as a diagnostic marker. Abe H, Matsubara T, Arai H, Doi T. Histol Histopathol; 2011 Apr 03; 26(4):531-41. PubMed ID: 21360446 [Abstract] [Full Text] [Related]
9. Mitofusin 2 attenuates the histone acetylation at collagen IV promoter in diabetic nephropathy. Mi X, Tang W, Chen X, Liu F, Tang X. J Mol Endocrinol; 2016 Nov 03; 57(4):233-249. PubMed ID: 27997345 [Abstract] [Full Text] [Related]
10. Angiotensin II-dependent Src and Smad1 signaling pathway is crucial for the development of diabetic nephropathy. Mima A, Matsubara T, Arai H, Abe H, Nagai K, Kanamori H, Sumi E, Takahashi T, Iehara N, Fukatsu A, Kita T, Doi T. Lab Invest; 2006 Sep 03; 86(9):927-39. PubMed ID: 16767106 [Abstract] [Full Text] [Related]
11. [Recent progress in understanding the molecular pathogenesis of diabetic nephropathy]. Abe H. Rinsho Byori; 2011 Feb 03; 59(2):179-86. PubMed ID: 21476304 [Abstract] [Full Text] [Related]
12. Novel Interplay Between Smad1 and Smad3 Phosphorylation via AGE Regulates the Progression of Diabetic Nephropathy. Ono H, Abe H, Sakurai A, Ochi A, Tominaga T, Tamaki M, Kishi S, Murakami T, Nagai K, Kohashi M, Doi T. Sci Rep; 2018 Jul 12; 8(1):10548. PubMed ID: 30002389 [Abstract] [Full Text] [Related]
13. All-trans retinoic acid suppresses bone morphogenetic protein 4 in mouse diabetic nephropathy through a unique retinoic acid response element. Tamaki M, Tominaga T, Fujita Y, Koezuka Y, Ichien G, Murakami T, Kishi S, Yamamoto K, Abe H, Nagai K, Doi T. Am J Physiol Endocrinol Metab; 2019 Mar 01; 316(3):E418-E431. PubMed ID: 30601699 [Abstract] [Full Text] [Related]
14. SOX9 protein induces a chondrogenic phenotype of mesangial cells and contributes to advanced diabetic nephropathy. Kishi S, Abe H, Akiyama H, Tominaga T, Murakami T, Mima A, Nagai K, Kishi F, Matsuura M, Matsubara T, Iehara N, Ueda O, Fukushima N, Jishage K, Doi T. J Biol Chem; 2011 Sep 16; 286(37):32162-9. PubMed ID: 21795715 [Abstract] [Full Text] [Related]
15. Camel milk attenuates the biochemical and morphological features of diabetic nephropathy: inhibition of Smad1 and collagen type IV synthesis. Korish AA, Abdel Gader AG, Korashy HM, Al-Drees AM, Alhaider AA, Arafah MM. Chem Biol Interact; 2015 Mar 05; 229():100-8. PubMed ID: 25617480 [Abstract] [Full Text] [Related]
16. Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism. Pugliese G, Pricci F, Romeo G, Pugliese F, Mené P, Giannini S, Cresci B, Galli G, Rotella CM, Vlassara H, Di Mario U. Diabetes; 1997 Nov 05; 46(11):1881-7. PubMed ID: 9356040 [Abstract] [Full Text] [Related]
17. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells. Poncelet AC, de Caestecker MP, Schnaper HW. Kidney Int; 1999 Oct 05; 56(4):1354-65. PubMed ID: 10504488 [Abstract] [Full Text] [Related]